EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer’s Disease

Francesca La Rosa iD, Simone Agostini iD, Federica Piancone, Ivana Marventano, Ambra Hernis, Chiara Fenoglio, Daniela Galimberti iD, Elio Scarpini, Marina Saresella iD, Mario Clerici iD

International Journal of Molecular Sciences · 11.05.2023 · 24 (10) · 8626

DOI: 10.3390/ijms24108626 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.05.2023. Verfasst von Francesca La Rosa und 9 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Fondazione Don Carlo Gnocchi, 20147 Milan, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease, MicroRNAs. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ricerca Corrente, Italian Ministry of Health, Fondazione Alessandro, Vincenzo Negroni Prati Morosini.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s Disease is the most common form of dementia; its key pathological findings include the deposition of extracellular-neurotoxic-plaques composed of amyloid-beta (Ab). AD-pathogenesis involves mechanisms that operate outside the brain, and new researches indicate that peripheral inflammation is an early event in the disease. Herein, we focus on a receptor known as triggering-receptor-expressed-on-myeloid-cells2 (TREM2), which promotes the optimal immune cells function required to attenuate AD-progression and is, therefore, a potential target as peripheral diagnostic and prognostic-biomarker for Alzheimer’s Disease. The objective of this exploratory study was to analyze: (1) soluble-TREM2 (sTREM2) plasma and cerebrospinal fluid concentration, (2) TREM2-mRNA, (3) the percentage of TREM2-expressing monocytes, and (4) the concentration of miR-146a-5p and miR-34a-5p suspected to influence TREM2 transcription. Experiments were performed on PBMC collected by 15AD patients and 12age-matched healthy controls that were unstimulated or treated in inflammatory (LPS) conditions and Ab42 for 24 h; Aβ42-phagocytosis was also analyzed by AMNIS FlowSight. Results although preliminary, due to limitations by the small sample-size, showed that in AD compared to HC: TREM2 expressing monocytes were reduced, plasma sTREM2 concentration and TREM2-mRNA were significantly upregulated and Ab42-phagocytosis was diminished (for all p < 0.05). miR-34a-5p expression was reduced (p = 0.02) as well in PBMC of AD, and miR-146 was only observed in AD cells (p = 0.0001).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMicroRNAsHumansLeukocytes, MononuclearAmyloid beta-PeptidesPhagocytosisMembrane GlycoproteinsReceptors, Immunologic

Stichwörter der Autor:innen

Ab-phagocytosisAlzheimer’s diseaseTREM2peripheral monocytesresearch biomarker

Substanzen

Amyloid beta-PeptidesMicroRNAsTREM2 protein, humanMembrane GlycoproteinsReceptors, Immunologic

Autor:innen und Institutionen

  • IRCCS Fondazione Don Carlo Gnocchi, 20147 Milan, Italy.
  • Department of Pathophysiology and Transplantation, University of Milan, 20100 Milan, Italy.
  • Fondazione Ca' Granda, IRCCS Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20100 Milan, Italy.

ORCID-Profile: Francesca La Rosa, Simone Agostini, Daniela Galimberti, Marina Saresella, Mario Clerici

Förderung

  • Ricerca Corrente, Italian Ministry of Health
  • Fondazione Alessandro
  • Vincenzo Negroni Prati Morosini
  • Fondazione Romeo
  • Enrica Invernizzi

Zitieren

APA

La Rosa, F., Agostini, S., Piancone, F., Marventano, I., Hernis, A., Fenoglio, C., Galimberti, D., Scarpini, E., Saresella, M., & Clerici, M. (2023). TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer’s Disease. International Journal of Molecular Sciences, 24(10), 8626. https://doi.org/10.3390/ijms24108626

Vancouver

La Rosa F, Agostini S, Piancone F, Marventano I, Hernis A, Fenoglio C, et al. TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer’s Disease. International Journal of Molecular Sciences. 2023;24(10):8626. doi:10.3390/ijms24108626

BibTeX
@article{LaRosa2023,
  author = {La Rosa, Francesca and Agostini, Simone and Piancone, Federica and Marventano, Ivana and Hernis, Ambra and Fenoglio, Chiara and Galimberti, Daniela and Scarpini, Elio and Saresella, Marina and Clerici, Mario},
  title = {TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {10},
  pages = {8626},
  doi = {10.3390/ijms24108626}
}
Kostenlos starten →